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Abstract: Pituitary apoplexy is a rare clinical event, used to occur spontaneously.   
Although, some predisposing factors for pituitary apoplexy is reported ie. head injury,    
digital cerebral angiography, bromocriptine therapy, coughing, lumbar puncture for CSF 
drainage, pneumoventriculography, even during surgery, in the immediate 
postoperative period and raised intracranial tension. Although pituitary apoplexy 
occurring following radiotherapy as primary treatment modality is reported, however, 
apoplexy occurring in residual adenoma following surgery, receiving adjuvant radiation 
therapy for residual adenoma is not reported in the literature. Authors reports two-cases 
of pituitary apoplexy, which occurred in the residual pituitary adenoma after a varying 
period in the follow-up period. These patients were previously operated by transcranial 
approach for decompression of the pituitary adenoma. The pituitary apoplexy occurred 
in one case after an interval of one and half years following surgical intervention for 
pituitary adenoma decompression and next case developed after five years. Both the 
cases had also received radiotherapy in the postoperative period for residual pituitary 
adenoma.  
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Introduction 
Pituitary apoplexy is clinical syndrome 
characterized by sudden onset of headache, 
commonly associated   with vomiting, 
meningeal irritability, and often 
ophthalmoplegia or visual deterioration (13, 
17-19). Apoplexy mostly occurs 
spontaneously, although in some cases may 
have predisposing factors including head 
endocrine manipulation, trauma, cerebral 
angiography, bromocriptine therapy, 
radiation therapy of pituitary adenoma lumbar 
puncture, and in the immediate postoperative 
period. (5, 6, 7, 8, 11)   We are reporting two 
cases of pituitary apoplexy, which was 
encountered in patients, who were operated 
  
 
 
 
290 | Satyarthee et al - Pituitary apoplexy in residual pituitary adenoma 
 
 
 
 
 
 
 
for pituitary adenoma and also received 
radiation therapy for residual many years prior 
to current occurrence of apoplexy. 
Illustrated Case I 
 A 42- year- old male presented to our 
neurosurgical services with a history of sudden 
onset headache, vomiting and rapidly 
progressive decline in the visual acuity for the 
last 15 days. He was operated for a pituitary 
adenoma four year back   by transsphenoidal 
approach. (Figures 1, 2, 3) The histopathology 
revealed chromophobe pituitary adenoma.  He 
also received radiotherapy in, for residual 
adenoma.  General examination was normal, 
with stable vitals. Neurological examination 
revealed visual acuity of 6/9 and 6/24 
respectively in the right and the left eye. He 
had bitemporal field defect. Fundi revealed 
bilateral primary optic atrophy. He also had 
right seventh cranial nerve upper motor-
neuron paresis. The rest of the neurological 
examination was normal. The haematological 
and biochemical profiles were normal. 
However, urinary specific gravity ranged from 
1008-1014. Hormonal profile showed Growth 
hormone - 2 (normal upto-5ng/ml), serum 
cortisol (8 am) - 0.8 µ g / dl (normal 5 -18), 
serum prolactin 12 ng /ml (normal 1.3-24), 
TSH- 2.8 µ IU /dl (normal 0.4- 4.6), free T3-
1.4 pg/ml (2.2- 5) and, free T4- 0.3 ng /dl (0.7-
1.8). X-ray chest was normal. Cranial CT scan 
revealed a pituitary macro-adenoma, showing 
fair enhancement with contrast agent. MRI 
sagittal view showed large sellar mass with 
suprasellar extension having heterogeneous 
hyperintense signal on T1 weighted image 
(Figure 4), and coronal T1 weighted image 
(Figures 5, 6) suggestive of  apoplectic bleed in 
the residual pituitary adenoma with further 
decent into sphenoid sinus due to deficient 
sellar floor, caused by previous surgery. There 
was associated mild hydrocephalus.  He 
underwent decompression of pituitary 
adenoma through sub-labaial   
transsphenoidal approach. Intra-operatively a 
large cyst containing fluid with evidence of old 
hemorrhage was encountered. Histopathology 
revealed chromophobe pituitary adenoma 
with evidence of haemorrhage. 
Immunohistochemistry morphological work-
up was negative prolactin and growth 
hormones. He showed unremarkable recovery 
in the postoperative period. His vision was 
6/9and 6/12 in the right and left eye 
respectively at the time of discharge from 
hospital on fourth postoperative day. He was 
kept on cortisol and thyroxin as maintenance 
therapy. He was well at last follow-up 3 year 
after second surgery and follow-up CT scan 
revealed no residual. 
 
 
Figure 1 - Contrast enhanced cranial CT, coronal 
view showing large enhancing sellar suprasellar mass 
with a right parasellar extension (pre- op) 
  
 
 
 
Romanian Neurosurgery (2016) XXX 2: 289-295 | 291 
 
 
 
 
 
 
 
 
Figure 2 - MRI brain, T!WI mage sowing 
homogeneous hyperintense mass (pre- op) 
 
 
Figure 3 - MRI brain, contrast enhanced, image 
sowing homogeneous hyperintense mass in sell 
causing encasement of bilateral internal carotid artery 
(pre-op) 
 
Figure 4 - MRI brain, T2WI , showing heterogeneous 
lesion in sella with areas of CSF like intensity 
suggestive of   apoplexy  in residual pituitary 
adenoma  ( Follow-up scan after 5 -year of surgery ) 
 
 
Figure 5 - MRI brain, T1W image, coronal section 
image, showing descent of suprasellar part with 
recurrent adenoma with apoplexy (Follow-up scan 
after 5 -year of surgery) 
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Figure 6 - MRI brain, sagittal section image, showing 
descent of suprasellar part with recurrent adenoma 
into sella due to deficient sellar floor due to past 
surgery, with apoplexy 
Illustrated Case II 
A 27 - year-old male presented with 
headache and sudden onset complete vision 
loss involving both eyes since three days prior 
to admission. He was operated pituitary 
macroadenoma by subfrontal route in 1997. 
He also received radiotherapy for residual 
pituitary adenoma. On admission his vitals 
were stable.  Neurological examination 
revealed, visual acuity in the right eye was just 
positive for perception of light and the left was 
negative for perception of light. Fundi revealed 
bilateral primary optic atrophy.  The routine 
haematological and biochemistry parameters 
were normal. Endocrinological evaluation 
showed serum cortisol - 14 µ g / dl (normal 5 -
18), serum prolactin 8 ng /ml (normal 1.3-24), 
TSH- 5 µ IU /dl (normal 0.4- 4.6), free T3-1.2 
pg/ml (2.2- 5) and, free T4- 0.4 ng /dl (0.7-1.8). 
Growth hormone-4 (upto-5ng/ml). Contrast 
CT scan of cranium revealed sellar-suprasellar 
mass with fluid level. A transnasal 
transsphenoidal radical decompression of 
tumour was carried out as an   emergency 
procedure. At surgery altered dark blood with 
grayish tumor which was evacuated. 
Morphological work-up on immune-
histochemistry was negative growth and 
prolactin hormones. He showed remarkable 
improvement in the vision in postoperative 
period, 6/36 in the right eye and 6/18 in the left 
eye. He was continued on cortisol and 
thyroxin replacement therapy. Contrast 
enhanced MRI done at six months after 
second surgery revealed small residual in 
suprasellar region only which was not abutting 
the optic chiasma.  Gamma knife therapy was 
given for residual adenoma. He was well at last 
follow-up one year after gamma knife therapy. 
Discussion  
Pituitary apoplexy is common clinical 
syndrome (1-4, 6-8, 15-19). Pituitary adenoma 
possesses comparatively bleeding frequency of 
5.4 times higher than any   primary 
intracranial neoplasm. (1) The incidence of 
pituitary adenoma with apoplectic 
presentation   varies in literature between 1.5 -
27.7 %. (2, 3, 12)  It is considered as complex 
clinical events, occurring following fulminate 
expansion of a pituitary tumor by 
haemorrhage, infarction, or combination of 
two, which involves adenoma and adjoining 
and surrounding pituitary gland. (4)  
Clinically it may have wide spectrum of 
presentation; which may vary from sub-
clinical infarction which could only be noticed 
during the surgery or on preoperative imaging 
to full blown apoplexy that mimics 
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subarachnoid haemorrhage. (3)  Although 
most cases are reported to occur 
spontaneously. Although, some predisposing 
factors are reported ie. head trauma, (6) 
cerebral angiography, (7) endocrine 
manipulation, (8) bromocriptine therapy, (5)  
coughing and sneezing, (9) radiotherapy of 
pituitary tumours (10, 11) lumbar puncture,  
(13) pneumoencephalography (13), and raised 
intracranial pressure, (13)  Weisberg et al (11)  
reported a series of 14 cases of  pituitary 
apoplexy, out of which eight cases were 
associated with radiation therapy.  These 
patients were treated with radiotherapy as 
primary mode of treatment without any prior 
surgery for pituitary adenoma.  Pituitary 
apoplexy occurred in five cases, which were 
receiving radiation therapy.  It occurred in 
three cases during the first week of initiation of 
radiotherapy, one in third weeks and another 
one towards completion stage of radiotherapy 
treatment. In rest of cases, the onset of 
pituitary apoplexy were noted three to four 
years after completion of radiation therapy. 
However, surgery was required in these cases 
after pituitary apoplexy during the course of 
radiation therapy. In the present study, our 
both cases were subjected to transcranial 
decompression of pituitary adenoma along 
with radiotherapy for the residual tumour and 
after a varying period of follow-up developed 
apoplectic manifestation. 
Various hypothesis put forward for 
pituitary apoplexy occurrence in post radiated 
pituitary adenoma, his rapid enlargement of 
cyst, which can cause compression over solid 
portion, resulting in ischemia and hypoxic 
necrosis. This leads to less radio-
responsiveness and more likely to undergo 
hemorrhagic necrosis with initiation of 
radiotherapy. Even radiotherapy can cause 
vascular damage to endothelium of fine blood 
vessel and damage neovascularity of tumour 
leading to hemorrhagic necrosis. Goel et al 
(14) reported pituitary apoplexy in the residual 
tumour after partial decompression following 
transcranial surgical approach in two cases. 
However, re-exploration was required within 
45 minutes in one case, while 12 hours after in 
the second case. Rovit et al (4) reported higher 
incidence of apoplexy in patients in 
acromegalic or ACTH producing adenoma. 
Weisberg et al (11) also noticed higher 
incidence in acromegalic after radiotherapy. 
However, our cases were with chromophobe 
pituitary adenoma.  
Goel et al (14) reported sudden release of 
feeding tumour vessel from internal carotid 
artery, compromise of venous drainage, 
tumour manipulation, swelling and 
compression of hypophyseal artery at 
diaphragma sella resulting in ischemia and 
secondary tumour necrosis after partial 
decompression of pituitary adenoma. They 
further observed that attempt should be made 
to excise these tumours as radically as possible. 
Similarly both of our patients underwent 
transsphenoidal decompression of pituitary 
adenoma and had uneventful postoperative 
period. A group of patients with residual 
pituitary adenoma following radiotherapy 
show re-growth, continuing vascular damage 
to blood vessel endothelium, and adenoma 
growth may outstrip the vascular requirement 
for adenoma leading to apoplexy, years after of 
surgery and radiotherapy. Damage to 
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neovascularity of tumour can lead to 
hemorrhagic necrosis. The mechanism of 
pituitary apoplexy is not clear. Ischemic 
necrosis of adenomatous tissue, compression 
of superior hypophyseal arteries against 
diaphgrama sellae and intrinsic vasculopathy 
of pituitary tumour has been suggested. 
 Further effect of apoplexy on pituitary 
function was assessed by Marouf et al, who 
analyzed a total of 19 cases of pituitary 
apoplexy, who underwent surgery for pituitary 
apoplexy. (21) Authors    assessed the function 
of residual pituitary gland function in the 
postoperative phase, only five cases retained 
normal pituitary function, while   eight   cases 
developed pan-hypopituitarism, and the rest 
six with partial hypopituitarism. The MRI 
study in the post-operative follow-up period 
demonstrated residual pituitary gland in 13 
patients, out of which four had normal 
functional pituitary gland. (21) 
Conclusion 
Every case of pituitary adenoma with past 
history of surgical intervention or 
radiotherapy, showing clinical feature of 
apoplexy, should be investigated with imaging 
and if needed urgent surgical opportunity may 
be given to preserve good neurological 
outcome.    The tumour decompression should 
be carried out as emergency procedure.  
During the first surgery itself, the aim should 
be radical decompression of adenoma to avoid 
residual   adenoma, which carries a potential 
risk for apoplexy. 
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